Dr Dan Andrews (2nd from right) and his group work on natural killer cells. Dan is co-author on a paper reviewing unconventional T cell targets for cancer immunotherapy. |
Anaesthesia
Hodgson CL et al. Myles PS. The impact of disability in survivors of critical illness. Intensive Care Med. 2017 Jul;43(7):992-1001. doi: 10.1007/s00134-017-4830-0. Epub 2017 May 22.
Hodgson CL et al. Myles PS. The impact of disability in survivors of critical illness. Intensive Care Med. 2017 Jul;43(7):992-1001. doi: 10.1007/s00134-017-4830-0. Epub 2017 May 22.
AIRMed
Bousquet J et al. O'Hehir R; MACVIA working group. Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study. Allergy. 2018 Mar 22. doi: 10.1111/all.13448. [Epub ahead of print]
Sun PF, Tian T, Chen LN, Fu RG, Xu SS, Ai H, Wang B, Zhang J, Si RY, Chai Z, Cooper ME, Ren ST. Ultrasound combined with microbubbles enhances the effects of methylprednisolone in lipopolysaccharide-induced human mesangial cells. J Pharmacol Exp Ther. 2018 Mar 16. pii: jpet.117.246223. doi: 10.1124/jpet.117.246223. [Epub ahead of print]
Zimmet P, Shaw J. Diabetes: Rising incidence of diabetes mellitus in youth in the USA. Nat Rev Endocrinol. 2017 Jul;13(7):379-380. doi: 10.1038/nrendo.2017.59. Epub 2017 May 19.
Gastroenterology
Christensen B, Colman RJ, Micic D, Gibson PR, Goeppinger SR, Yarur A, Weber CR, Cohen RD, Rubin DT. Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 Mar 19;24(4):849-860. doi: 10.1093/ibd/izx067.
Godfrey DI, Le Nours J, Andrews DM, Uldrich AP, Rossjohn J. Unconventional T Cell Targets for Cancer Immunotherapy. Immunity. 2018 Mar 20;48(3):453-473. doi: 10.1016/j.immuni.2018.03.009.
Yao CK, Rotbart A, Ou JZ, Kalantar-Zadeh K, Muir JG, Gibson PR. Modulation of colonic hydrogen sulfide production by diet and mesalazine utilizing a novel gas-profiling technology. Gut Microbes. 2018 Mar 21:0. doi:10.1080/19490976.2018.1451280. [Epub ahead of print]
Kiely P, Wood EM, Cheng AC. Emerging infectious disease agents and blood safety in Australia: spotlight on Zika virus. Med J Aust. 2018 Feb 5;208(2):96.
MAPrc
Kulkarni J, Thomas N, Hudaib AR, Gavrilidis E, Grigg J, Tan R, Cheng J, Arnold A, Gurvich C. Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial. CNS Drugs. 2018 Mar 16. doi: 10.1007/s40263-018-0506-8. [Epub ahead of print]
Medicine
Kulkarni J, Thomas N, Hudaib AR, Gavrilidis E, Grigg J, Tan R, Cheng J, Arnold A, Gurvich C. Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial. CNS Drugs. 2018 Mar 16. doi: 10.1007/s40263-018-0506-8. [Epub ahead of print]
Medicine
Callisaya ML, Launay CP, Srikanth VK, Verghese J, Allali G, Beauchet O9.4479. Cognitive status, fast walking speed and walking speed reserve-the Gait and Alzheimer Interactions Tracking (GAIT) study. Geroscience. 2017 Apr;39(2):231-239. doi: 10.1007/s11357-017-9973-y. Epub 2017 Apr 3.
Schneider EK, McQuade RM, Carbone VC, Reyes-Ortega F, Wilson JW, Button B, Saito A, Poole DP, Hoyer D, Li J, Velkov T. The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites. ERJ Open Res. 2018 Mar 13;4(1). pii: 00127-2017. doi: 10.1183/23120541.00127-2017. eCollection 2018 Jan.
Anderson PM, Jones NC, O'Brien TJ, Pinault D. The N-Methyl d-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway. Cereb Cortex. 2017 Jun 1;27(6):3172-3185. doi: 10.1093/cercor/bhw168.
Sharma P, Wright DK, Johnston LA, Powell KL, Wlodek ME, Shultz SR, O'Brien TJ, Gilby KL. Differences in white matter structure between seizure prone (FAST) and seizure resistant (SLOW) rat strains. Neurobiol Dis. 2017 Aug;104:33-40. doi: 10.1016/j.nbd.2017.04.022. Epub 2017 May 1.
Surgery
Bendinelli C, Ku D, Nebauer S, King KL, Howard T, Gruen R, Evans T, Fitzgerald M, Balogh ZJ. A tale of two cities: prehospital intubation with or without paralysing agents for traumatic brain injury. ANZ J Surg. 2018 Mar 23. doi: 10.1111/ans.14479. [Epub ahead of print]
Wertheimer A, Olaussen A, Perera S, Liew S, Mitra B. Fractures of the femur and blood transfusions. Injury. 2018 Mar 7. pii: S0020-1383(18)30115-3. doi: 10.1016/j.injury.2018.03.007. [Epub ahead of print]
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.